Atara Biotherapeutics (ATRA) Non-cash Items (2013 - 2026)

Atara Biotherapeutics has reported Non-cash Items for 13 years, with the latest figure at $72090.0 in Q1 2026.

• For the quarter ending Q1 2026, Non-cash Items fell 99.16% year-over-year to $72090.0; the trailing twelve-month figure through Mar 2026 stood at $72090.0 (down 99.16% YoY), and the FY2025 full-year result was $23000.0, down 14.81% from the prior year.
• Non-cash Items for Q1 2026 stood at $72090.0, up from $23000.0 in the prior quarter.
• The five-year high for Non-cash Items was $35.7 million in Q1 2023, with the low at $14000.0 in Q3 2025.
• Historically, Non-cash Items has averaged $10.1 million across 5 years, with a median of $675000.0 in 2022.
• Annual changes were most pronounced in 2022 — Non-cash Items sank 99.81% — and 2023, when it jumped 25334.78%.
• Atara Biotherapeutics' Non-cash Items stood at $42000.0 in 2022, then soared by 55614.29% to $23.4 million in 2023, then sank by 99.88% to $27000.0 in 2024, then dropped by 14.81% to $23000.0 in 2025, then soared by 213.43% to $72090.0 in 2026.
• The last three Non-cash Items figures came in at $72090.0 (Q1 2026), $23000.0 (Q4 2025), and $14000.0 (Q3 2025), per Business Quant data.